Recombinant Peromyscus maniculatus Alcohol Dehydrogenase 6 (ADH6) is a genetically engineered enzyme produced to study alcohol metabolism and detoxification pathways in this species. ADH6 belongs to the medium-chain dehydrogenase/reductase (MDR) superfamily and plays roles in oxidizing alcohols and reducing aldehydes, similar to its homologs in other mammals . Its recombinant form enables precise biochemical characterization and application in research models, particularly for understanding ethanol metabolism in Peromyscus maniculatus, a species used in biomedical studies due to its unique ADH-negative mutants .
Yeast: Preferred for eukaryotic post-translational modifications .
E. coli: Cost-effective for high-yield production but lacks modifications .
Affinity Chromatography: His-tag binding to nickel columns .
Buffer Composition: 20 mM Tris-HCl (pH 8.0), 30% glycerol, 0.15 M NaCl, 1 mM DTT for stability .
Storage: -20°C or -80°C with carrier proteins (e.g., 0.1% BSA) to prevent aggregation .
Antibody Production: Serves as an antigen for generating monoclonal antibodies .
Enzyme Kinetics: Used to compare ADH activity across species or under genetic modifications .
Toxicology Models: ADH-negative Peromyscus strains help isolate ADH6’s role in allyl alcohol hepatotoxicity .
Substrate Profiling: Comprehensive kinetic studies are needed to define Peromyscus ADH6’s substrate repertoire .
Structural Modeling: Cryo-EM or X-ray crystallography could resolve active-site differences compared to human ADH6 .
In Vivo Functional Studies: Leveraging CRISPR-edited Peromyscus to validate ADH6’s metabolic roles .
Peromyscus maniculatus ADH6 (Alcohol Dehydrogenase 6, Class V) is a 375 amino acid protein belonging to the zinc-containing alcohol dehydrogenase family. The full amino acid sequence begins with MSTAGKVIRC and continues through a structured catalytic domain containing zinc-binding motifs essential for its enzymatic activity . The protein maintains the general structural features of class V alcohol dehydrogenases, including NAD(H) binding domains and substrate-binding pockets. Unlike some other mammalian ADHs, the deer mouse ADH6 exhibits unique evolutionary adaptations that may relate to metabolic requirements specific to this species.
Peromyscus maniculatus ADH6 represents a class V alcohol dehydrogenase that differs from other classes in several key aspects:
Substrate specificity: While all ADHs catalyze the oxidation of alcohols, P. maniculatus ADH6 shows tissue-specific expression patterns and somewhat different substrate preferences compared to other ADH classes .
Genetic lineage: Research has identified that deer mice possess multiple ADH genes, including Adh-1 (a class I ADH) and Adh-2, which represents a novel class of mammalian ADH with distinct evolutionary origins .
Expression profiles: Biochemical analyses suggest P. maniculatus expresses at least three ADH polypeptides in different tissues with varying substrate specificities .
Understanding these differences is crucial when using this protein as a model for comparative studies against human or other mammalian ADH enzymes.
Based on homology to other ADH6 enzymes, P. maniculatus ADH6 primarily catalyzes:
NAD-dependent oxidation of primary alcohols to corresponding aldehydes
Oxidation of secondary alcohols to corresponding ketones
The enzyme forms part of the metabolic pathway responsible for alcohol detoxification in mammals. The recombinant version maintains these catalytic properties, making it suitable for studying alcohol metabolism in controlled experimental settings . The enzyme requires NAD+ as a cofactor for its oxidative activities, and the catalytic reaction follows a sequential ordered mechanism where the coenzyme binds first, followed by the substrate.
Recombinant P. maniculatus ADH6 offers valuable insights for evolutionary studies through:
Phylogenetic analysis: Comparing ADH6 sequences across mammalian species reveals evolutionary relationships and functional divergence patterns. The deer mouse represents an important model as it exhibits unique ADH gene variants not found in laboratory mice .
Structure-function relationship studies: The recombinant protein allows researchers to investigate how sequence variations translate to functional differences in enzyme activity. This can be accomplished through:
Site-directed mutagenesis to mimic evolutionary changes
Kinetic parameter comparisons across species
Structural modeling and docking studies to visualize substrate interactions
Adaptive metabolism analysis: Researchers can examine how variations in ADH6 across mammalian lineages relate to dietary adaptations and environmental pressures, particularly regarding alcohol metabolism capacities .
The comparative data obtained can provide insights into how alcohol metabolism evolved across different mammalian lineages in response to varying ecological niches.
For comprehensive substrate specificity analysis:
Parallel enzyme kinetics studies:
Determine Km and Vmax values for P. maniculatus ADH6 with various substrates
Compare kinetic parameters with other mammalian ADHs under identical conditions
Use Lineweaver-Burk or Eadie-Hofstee plots to visualize differences
Structural analysis approaches:
Homology modeling based on crystallographic data from related ADHs
Molecular docking of diverse substrates to identify binding pocket differences
MD simulations to analyze protein-substrate interactions
Isothermal titration calorimetry (ITC):
Measure the thermodynamic parameters of substrate binding
Determine binding affinity constants for different substrates
Compare with human and other mammalian ADH enzymes
High-throughput substrate screening:
Test activity against libraries of potential substrates
Identify unique specificities for evolutionary significance
Develop activity profiles for comparison across species
This multi-faceted approach will reveal how P. maniculatus ADH6 differs functionally from other mammalian ADHs and may identify novel substrates or activities specific to this enzyme .
The choice of expression system significantly impacts recombinant P. maniculatus ADH6 properties:
Yeast expression system (as used in ABIN1610357):
Alternative expression systems:
E. coli: Higher yield but may form inclusion bodies requiring refolding
Mammalian cells: Better for studying mammalian-specific modifications
Cell-free systems: Useful for rapid production but may lack proper folding
Tag influence considerations:
His-tag impact on structure minimal but may affect metal binding properties
Position of tag (N vs C-terminal) can differently impact catalytic activity
Removal of tag may be necessary for certain structural studies
When comparing experimental results across studies, researchers should account for these expression system variables. For the most accurate structure-function studies, validation against native enzyme (when available) is recommended .
For optimal measurement of P. maniculatus ADH6 enzymatic activity:
Buffer composition:
100 mM sodium phosphate or Tris-HCl buffer (pH 7.5-8.5)
150 mM NaCl for stability
0.1-1 mM ZnCl₂ (to maintain zinc cofactor)
Reaction conditions:
Temperature: 25-37°C (37°C approximates physiological conditions)
pH optimum: Typically 7.5-8.5 (determine empirically)
NAD⁺ concentration: 1-2 mM (saturating)
Substrate concentration range: 0.1-100 mM (for Km determination)
Activity measurement methods:
Spectrophotometric assay: Monitor NADH formation at 340 nm
Calculated using extinction coefficient (ε) of 6,220 M⁻¹cm⁻¹
Initial velocity measurements (first 5-10% of reaction)
Controls and standards:
Heat-inactivated enzyme negative control
Commercial ADH from similar sources as positive control
Blank reaction without substrate
Researchers should optimize these conditions for their specific experimental setup. The recombinant P. maniculatus ADH6 typically shows >90% purity and is suitable for these biochemical assays when obtained from commercial sources .
For efficient purification of His-tagged recombinant P. maniculatus ADH6:
Immobilized Metal Affinity Chromatography (IMAC):
Equilibrate Ni-NTA resin with binding buffer (50 mM Na₂HPO₄, 300 mM NaCl, 10 mM imidazole, pH 8.0)
Load cleared lysate onto column
Wash with binding buffer containing 20-30 mM imidazole
Elute with step gradient of imidazole (100-250 mM)
Monitor protein elution by Bradford assay or A280
Secondary purification steps:
Size exclusion chromatography (Superdex 200) to remove aggregates and obtain homogeneous protein
Ion exchange chromatography for removal of charged contaminants
Consider affinity tag removal using TEV protease if tag impacts function
Quality control:
SDS-PAGE analysis with Coomassie staining (should show >90% purity)
Western blot using anti-His antibodies
Activity assay using standard alcohol substrates
Mass spectrometry to confirm identity and integrity
Storage considerations:
Store at -80°C in 20% glycerol, 50 mM phosphate buffer, pH 7.5
Avoid repeated freeze-thaw cycles
Add reducing agent (1-5 mM DTT) to prevent oxidation of cysteine residues
This protocol typically yields active enzyme with >90% purity as determined by SDS-PAGE, suitable for most biochemical and structural studies .
For robust cross-species ADH6 comparative studies:
Standardized expression systems:
Express all proteins in the same host (e.g., yeast or E. coli)
Use identical purification tags and protocols
Confirm similar purity levels (>90%) before comparison
Parallel characterization setup:
Determine basic parameters (pH optima, temperature stability, cofactor preferences) simultaneously
Use identical buffer conditions and substrate concentrations
Process all samples in the same analytical batch when possible
Kinetic analysis design:
Measure initial velocities across a range of substrate concentrations (0.1 × Km to 10 × Km)
Analyze data with consistent software and models (Michaelis-Menten, allosteric models)
Calculate and compare key parameters (kcat, Km, kcat/Km) with statistical analysis
Standardized reporting:
Document full experimental conditions in publications
Present results in comparative tables showing percent differences
Include positive controls (well-characterized ADHs) in experiments
This approach minimizes variables that could confound true species differences. When investigating evolutionary aspects, researchers should include ADH6 from species at varying evolutionary distances to establish meaningful phylogenetic patterns .
Mutations in P. maniculatus ADH6 can significantly impact enzyme properties in predictable ways based on the location:
Catalytic domain mutations:
Histidine residues in the zinc-binding motif: Severely reduce or eliminate activity
Substrate-binding pocket residues: Alter substrate specificity and Km values
NAD⁺-binding residues: Affect cofactor affinity and catalytic rate
Stability-affecting mutations:
Core hydrophobic residues: May destabilize tertiary structure
Surface exposed cysteines: Can form aberrant disulfide bonds affecting stability
Interface residues for dimerization: May disrupt quaternary structure
Experimental approaches to study mutation effects:
Site-directed mutagenesis to introduce specific changes
Thermal shift assays to measure stability changes (ΔTm)
Circular dichroism to assess secondary structure alterations
Activity assays with increasing denaturant concentrations
Natural variants analysis:
Understanding these structure-function relationships helps elucidate evolutionary adaptations and can inform protein engineering efforts for enhanced stability or altered substrate specificity .
To elucidate the 3D structure of P. maniculatus ADH6:
These complementary approaches provide comprehensive structural insights, particularly when integrated with functional data from enzyme kinetics and substrate binding studies .
For robust inhibitor studies with P. maniculatus ADH6:
Inhibitor selection strategy:
Competitive inhibitors: Target the substrate binding site
Uncompetitive inhibitors: Bind only to enzyme-substrate complex
Mixed inhibitors: Affect both free enzyme and enzyme-substrate complex
Start with known inhibitors of other mammalian ADHs as a baseline
Experimental design considerations:
Determine inhibition mechanism through Lineweaver-Burk plots
Calculate Ki values under standardized conditions
Test inhibitor specificity against other ADH classes
Investigate structure-activity relationships with related compounds
Technical execution:
Pre-incubate enzyme with inhibitor before adding substrate
Include solvent controls (for DMSO or ethanol-dissolved inhibitors)
Use multiple inhibitor concentrations (0.1-10× expected Ki)
Account for potential time-dependent inhibition
Advanced analysis:
IC₅₀ determination with statistical validation
Residence time measurements for tight-binding inhibitors
Thermal shift assays to confirm direct binding
Computational docking to predict binding modes
Comparative dimensions:
Test the same inhibitors against human ADH6 for translational relevance
Compare with inhibition profiles of other mammalian ADHs
Correlate inhibition patterns with structural differences
These methodological considerations ensure reliable inhibition data that can inform drug development and provide insights into active site architecture and enzyme mechanism .
When analyzing substrate specificity differences:
Quantitative interpretation framework:
Calculate specificity constants (kcat/Km) for each substrate across species
Normalize data to a common substrate for relative comparison
Construct specificity profiles using radar charts for visual comparison
Calculate Z-scores to highlight statistically significant differences
Structure-based interpretation:
Map amino acid differences to the 3D structural model
Focus on residues lining the substrate binding pocket
Correlate binding pocket volume with substrate size preferences
Use molecular docking to visualize altered binding modes
Evolutionary context analysis:
Consider the ecological and dietary factors for P. maniculatus
Assess whether differences align with known selective pressures
Compare with other species occupying similar ecological niches
Examine substrate preferences in the context of natural alcohol exposure
Methodological considerations for interpretation:
Account for different expression systems when comparing published data
Consider the impact of purification tags on substrate binding
Ensure pH and temperature conditions are standardized
Use multiple substrate concentrations to establish accurate kinetic parameters
This comprehensive interpretation approach helps distinguish functionally significant differences from experimental variation and provides evolutionary context to biochemical findings .
For robust statistical analysis of ADH6 kinetic data:
Primary data fitting methods:
Non-linear regression using Michaelis-Menten equation for standard kinetics
Enzyme inhibition models (competitive, non-competitive, uncompetitive)
Global fitting for complex mechanisms with multiple parameters
Bootstrap analysis to estimate parameter confidence intervals
Statistical comparison tests:
ANOVA for comparing multiple experimental conditions
Tukey's or Dunnett's post-hoc tests for multiple comparisons
t-tests for pairwise comparisons of kinetic parameters
Mann-Whitney U test for non-normally distributed data
Experimental design considerations:
Minimum of triplicate independent experiments
Technical replicates within each experiment (n≥3)
Power analysis to determine appropriate sample size
Randomization of sample processing order
Advanced statistical approaches:
Principal component analysis for multivariate substrate specificity data
Hierarchical clustering to identify substrate preference patterns
Bootstrapping for robust parameter estimation
Monte Carlo simulations for error propagation in complex calculations
Visualization techniques:
Include residual plots to verify goodness of fit
Forest plots for comparing kinetic parameters across conditions
Heat maps for visualizing substrate preference patterns
Box plots showing data distribution and outliers
These statistical approaches ensure reliable interpretation of kinetic data while accounting for experimental variability and complex enzyme behaviors .
When addressing conflicting literature findings:
Systematic comparative analysis:
Create a comprehensive table of contradictory results with experimental conditions
Categorize discrepancies by type: substrate specificity, kinetic parameters, expression patterns
Identify methodological differences that could explain contradictions
Examine species differences in sequence and structure as potential explanations
Methodological reconciliation:
Standardize units and reference conditions across studies
Account for different expression systems and purification methods
Consider the impact of different assay methods and detection limits
Re-analyze raw data when available using consistent analytical approaches
Targeted validation experiments:
Design experiments specifically addressing contradictory points
Include positive and negative controls relevant to contradictory findings
Use multiple independent methods to verify key findings
Consider reproducibility across different laboratories
Biological context integration:
Consider tissue-specific expression patterns when interpreting functional differences
Examine whether contradictions align with evolutionary adaptations
Investigate potential post-translational modifications affecting activity
Account for the physiological relevance of in vitro conditions
Meta-analysis techniques:
Apply formal meta-analysis when sufficient quantitative data exists
Weight studies based on methodological rigor and sample size
Identify moderator variables that explain heterogeneity in findings
Present forest plots to visualize effect sizes across studies
This structured approach helps resolve apparent contradictions and can advance understanding of true species differences versus methodological artifacts in ADH6 research .